The global transplant diagnostics market is expected to grow at a CAGR of 7.4% from 2020 to 2027 and expected to reach value of around US$ 5,902.2 Mn by 2027.
Transplant diagnostics is an integral procedure in organ transplantation. This is performed to check the compatibility between donor and the recipient and it plays a crucial role at every stage of organ transplantation. Additionally, assist physician and surgeons during the overall procedure of transplantation to control the risk of organ failure or transplant rejection. Moreover, organ transplantation is performed in order to replace the non-functioning organ with functioning one to provide a normal life to the patient.
Market Dynamics
The increasing number of transplant procedures along with the increasing awareness leads to increased number of organ donors is primarily driving the market value. Technological advancements associated with the transplant diagnostics coupled with the increasing public-private funding for target research activities are supporting the market value. The rising prevalence of infectious diseases is further accelerating the market value. Moreover, the rising adoption of cross-matching and chimerism testing during pre & post-transplantation is anticipated to create potential demand during the estimated period from 2020 to 2027.
On the other side, lack of favorable reimbursement policies, high cost of organ transplant, social and ethical issues related to organ transplantation are some of the factors projected to hamper the growth over the forecast period.
Reagents & Consumables accounted for the major share in the market
By product & service, the reagents & consumables segment is leading the global market owing to the increasing adoption of Reagents & Consumables as well as a repeat purchase. The segment is also projected to maintain its dominance over the estimated period from 2020 to 2027.
The market research study on “Transplant Diagnostics Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027”, offers a detailed insight into the global transplant diagnostics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global transplant diagnostics market, its product & service, technology, transplant type, end user, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global transplant diagnostics market size and volume, and segment markets by product & service, technology, transplant type, end user, and geography along with the information on companies operating in the market. The Transplant Diagnostics market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.
North America region accounted for the major share in 2019
North America is leading the market with a major share in terms of value. The region is also projected to maintain its dominance over the estimated period. The well-established healthcare infrastructure with the highly developed healthcare system is primarily driving the regional market value. High adoption of personalized medicines, availability of skilled professionals, high adoption of innovative transplant diagnostic technologies, the large volume of organ transplantation procedures performed, technological advancements coupled with the higher healthcare expenditure are other important factors supporting the regional market value. Apart from these, the presence of global players in the regional market such as Bio-Rad Laboratories, Inc., CareDx, Dickinson and Company, Hologic, Illumina, Inc., Immucor, Inc., and Luminex Corporation is further supporting the regional market value.
The players profiled in the report include BAG Healthcare, Becton, Biofortuna (UK), bioMérieux S.A., Bio-Rad Laboratories, Inc. (US), CareDx (US), Dickinson and Company (US), F. Hoffman-La Roche Ltd. (Switzerland), GenDx (Netherlands), Hologic (US), Illumina, Inc. (US), Immucor, Inc. (US), Luminex Corporation (US), QIAGEN N.V. (Netherlands), Takara Bio, and Thermo Fisher Scientific Inc. (US).
Market Segmentation
Market By Product & Service
- Reagents & Consumables
- Instruments
- Software & Services
Market By Technology
Molecular Assay
- PCR-based Molecular Assay
- Sequencing-based Molecular Assay
Non-molecular Assay
- Serological Assay
- Mixed Lymphocyte Culture Assay
Market By Transplant Type
Solid Organ Transplantation
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Pancreas Transplantation
- Other Organ Transplantations
Stem Cell Transplantation
Soft Tissue Transplantation
Bone marrow Transplantation
Market By End User
- Independent Reference Laboratories
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Transplant Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Transplant Diagnostics Market By Product & Service
1.2.2.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Product & Service (2016-2027)
1.2.2.2. Global Transplant Diagnostics Market Revenue Share By Product & Service in 2019
1.2.2.3. Reagents & Consumables
1.2.2.4. Instruments
1.2.2.5. Software & Services
1.2.3. Transplant Diagnostics Market By Technology
1.2.3.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Technology (2016-2027)
1.2.3.2. Molecular Assay
1.2.3.2.1. PCR-based Molecular Assay
1.2.3.2.2. Sequencing-based Molecular Assay
1.2.3.3. Non-molecular Assay
1.2.3.3.1. Serological Assay
1.2.3.3.2. Mixed Lymphocyte Culture Assay
1.2.4. Transplant Diagnostics Market By Transplant Type
1.2.4.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Transplant Type (2016-2027)
1.2.4.2. Solid Organ Transplantation
1.2.4.2.1. Kidney Transplantation
1.2.4.2.2. Liver Transplantation
1.2.4.2.3. Heart Transplantation
1.2.4.2.4. Lung Transplantation
1.2.4.2.5. Pancreas Transplantation
1.2.4.2.6. Other Organ Transplantations
1.2.4.3. Stem Cell Transplantation
1.2.4.4. Soft Tissue Transplantation
1.2.4.5. Bone marrow Transplantation
1.2.5. Transplant Diagnostics Market By End User
1.2.5.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By End User (2016-2027)
1.2.5.2. Independent Reference Laboratories
1.2.5.3. Hospitals & Transplant Centers
1.2.5.4. Research Laboratories & Academic Institutes
1.2.6. Transplant Diagnostics Market By Geography
1.2.6.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison by Geography (2016-2027)
1.2.6.2. North America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.3. Europe Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.4. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.5. Latin America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
1.2.6.6. Middle East and Africa (MEA) Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Transplant Diagnostics Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Transplant Diagnostics Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Transplant Diagnostics Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Transplant Diagnostics Major Manufacturers in 2019
CHAPTER 4. TRANSPLANT DIAGNOSTICS MARKET BY PRODUCT & SERVICE
4.1. Global Transplant Diagnostics Revenue By Product & Service
4.2. Reagents & Consumables
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Instruments
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Software & Services
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. TRANSPLANT DIAGNOSTICS MARKET BY TECHNOLOGY
5.1. Global Transplant Diagnostics Revenue By Technology
5.2. Molecular Assay
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.2.3. PCR-based Molecular Assay
5.2.4. Sequencing-based Molecular Assay
5.3. Non-molecular Assay
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3.3. Serological Assay
5.3.4. Mixed Lymphocyte Culture Assay
CHAPTER 6. TRANSPLANT DIAGNOSTICS MARKET BY TRANSPLANT TYPE
6.1. Global Transplant Diagnostics Revenue By Transplant Type
6.2. Solid Organ Transplantation
6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.2.3. Kidney Transplantation
6.2.4. Liver Transplantation
6.2.5. Heart Transplantation
6.2.6. Lung Transplantation
6.2.7. Pancreas Transplantation
6.2.8. Other Organ Transplantations
6.3. Stem Cell Transplantation
6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Soft Tissue Transplantation
6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.5. Bone marrow Transplantation
6.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 7. TRANSPLANT DIAGNOSTICS MARKET BY END USER
7.1. Global Transplant Diagnostics Revenue By End User
7.2. Independent Reference Laboratories
7.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.3. Hospitals & Transplant Centers
7.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.4. Research Laboratories & Academic Institutes
7.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 8. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
8.1. North America Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. North America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. U.S.
8.3.1. U.S. Transplant Diagnostics Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
8.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
8.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
CHAPTER 9. EUROPE TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
9.1. Europe Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Europe Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
9.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
9.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
9.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
9.6.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
9.7.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
CHAPTER 10. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
10.1. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Asia-Pacific Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.6.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.6.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.7.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.7.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
10.8.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
10.8.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
10.8.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
CHAPTER 11. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
11.1. Latin America Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Latin America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
11.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
11.4. Mexico
11.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
11.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
11.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
CHAPTER 12. MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
12.1. Middle East & Africa Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
12.2. Middle East & Africa Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
12.3. GCC
12.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
12.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
12.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
12.4. South Africa
12.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
12.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
12.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
12.5. Rest of Middle East & Africa
12.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
12.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
12.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. BAG Healthcare
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Becton
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Biofortuna (UK)
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. bioMérieux S.A.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bio-Rad Laboratories, Inc. (US)
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. CareDx (US)
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Dickinson and Company (US)
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. F. Hoffman-La Roche Ltd. (Switzerland)
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. GenDx (Netherlands)
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
